PE20091626A1 - NEW REGIME OF DROSPIRENONE / 17ß-ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND SET OF ELEMENTS (KIT) FOR ITS APPLICATION - Google Patents
NEW REGIME OF DROSPIRENONE / 17ß-ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND SET OF ELEMENTS (KIT) FOR ITS APPLICATIONInfo
- Publication number
- PE20091626A1 PE20091626A1 PE2009000374A PE2009000374A PE20091626A1 PE 20091626 A1 PE20091626 A1 PE 20091626A1 PE 2009000374 A PE2009000374 A PE 2009000374A PE 2009000374 A PE2009000374 A PE 2009000374A PE 20091626 A1 PE20091626 A1 PE 20091626A1
- Authority
- PE
- Peru
- Prior art keywords
- phase
- pharmaceutical product
- estradiol
- drospirenone
- kit
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 229940127557 pharmaceutical product Drugs 0.000 title abstract 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title 2
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title 1
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title 1
- 229960004845 drospirenone Drugs 0.000 title 1
- VOXZDWNPVJITMN-UHFFFAOYSA-N 13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2C3CCC(C)(C(CC4)O)C4C3CCC2=C1 VOXZDWNPVJITMN-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000001794 hormone therapy Methods 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000902 placebo Substances 0.000 abstract 1
- 229940068196 placebo Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UN PRODUCTO FARMACEUTICO COMBINADO TRIFASICO DE A) 24 UNIDADES DE DOSIFICACION DIARIAS COMPRENDIDAS EN TRES FASES DONDE CADA FASE CONTIENE 8 UNIDADES DE DOSIFICACION DIARIAS, EN DONDE CADA UNIDAD DE DOSIFICACION CONTIENE: i) DROSPIRENONA (DRSP) EN UNA CANTIDAD DE 1,5MG A 3,0MG EN CADA FASE; ii) 17 ESTRADIOL (E2) QUE SE ENCUENTRA EN UNA CANTIDAD DE 1,0MG EN LA PRIMERA FASE, 1,5MG EN LA SEGUNDA FASE Y 2,0MG EN LA TERCERA FASE; E iii) 5-METIL-(6S)-TETRAHIDROFOLATO EN UNA CANTIDAD DE 0,1MG A 10MG; Y B) 4 PILDORAS DE PLACEBO SIN INGREDIENTE ACTIVO. DICHO PRODUCTO FARMACEUTICO ES UTIL PARA LA CONTRACEPCION EN MUJERES PREMENOPAUSICAS Y PARA LA TERAPIA HORMONAL EN MUJERES PERIMENOPAUSICASIT REFERS TO A THREE-PHASE COMBINED PHARMACEUTICAL PRODUCT OF A) 24 DAILY DOSING UNITS INCLUDED IN THREE PHASES, WHERE EACH PHASE CONTAINS 8 DAILY DOSAGE UNITS, WHERE EACH DOSAGE UNIT CONTAINS 1 DROSPON (i) DROSPONE IN 1 AMOUNT OF: i) DROSPONE OF 1) 5MG TO 3.0MG IN EACH PHASE; ii) 17 ESTRADIOL (E2) WHICH IS IN A QUANTITY OF 1.0MG IN THE FIRST PHASE, 1.5MG IN THE SECOND PHASE AND 2.0MG IN THE THIRD PHASE; E iii) 5-METHYL- (6S) -TETRAHYDROPHOLATE IN AN AMOUNT OF 0.1MG TO 10MG; AND B) 4 PLACEBO PILLS WITHOUT ACTIVE INGREDIENT. SAID PHARMACEUTICAL PRODUCT IS USEFUL FOR CONTRACEPTION IN PREMENOPAUSAL WOMEN AND FOR HORMONE THERAPY IN PERIMENOPAUSAL WOMEN
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3612908P | 2008-03-13 | 2008-03-13 | |
| US4041008P | 2008-03-28 | 2008-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091626A1 true PE20091626A1 (en) | 2009-11-22 |
Family
ID=41665343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2009000374A PE20091626A1 (en) | 2008-03-13 | 2009-03-13 | NEW REGIME OF DROSPIRENONE / 17ß-ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND SET OF ELEMENTS (KIT) FOR ITS APPLICATION |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR072246A1 (en) |
| PE (1) | PE20091626A1 (en) |
| UY (1) | UY31708A (en) |
-
2009
- 2009-03-13 UY UY0001031708A patent/UY31708A/en not_active Application Discontinuation
- 2009-03-13 PE PE2009000374A patent/PE20091626A1/en not_active Application Discontinuation
- 2009-03-13 AR ARP090100901 patent/AR072246A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR072246A1 (en) | 2010-08-18 |
| UY31708A (en) | 2009-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6160297A2 (en) | USE OF ESTRADIOL VALERATE OR 17BETA-ESTRADIOL IN COMBINATION OF DIENOGEST IN AN ORAL THERAPY TO MAINTAIN AND / OR INCREASE THE FEMALE FREE | |
| UY33343A (en) | ORAL SOLID DOSAGE FORMS WITH VERY LOW DOSE FOR HRT | |
| HRP20220312T1 (en) | Compounds and their uses for alleviating menopause-associated symptoms | |
| AR084229A2 (en) | POLYPHASIC PREPARED FOR CONTRACEPTION BASED ON A NATURAL STROGEN | |
| MX2014008283A (en) | FORMULATION OF PROLONGED RELEASE TO REDUCE THE FREQUENCY OF URINATING AND METHODS OF USE OF THIS. | |
| CL2008000999A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND 17BETA ESTRADIOL; PHARMACEUTICAL KIT THAT INCLUDES SUCH COMPOSITION, USEFUL FOR HORMONAL THERAPY AND CONTRACEPTION IN WOMEN. | |
| AR087488A1 (en) | USE OF COMPOSITIONS TO DELAY THE START OF THE CATAGENA HAIR PHASE | |
| PE20091626A1 (en) | NEW REGIME OF DROSPIRENONE / 17ß-ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND SET OF ELEMENTS (KIT) FOR ITS APPLICATION | |
| CY1108265T1 (en) | STRONG INTERMEDIATE PHARMACEUTICAL FORM FOR CONTRACT | |
| CL2011000283A1 (en) | Combined polyphasic preparation comprising 4 phases with dose units containing first: <3 mg of estradiol (et), second: some with <2 mg of et and 2 mg of dienogest (dg) and others with <2 mg of et y 3 mg of dg, third: <1 mg of et and fourth: placebo; Useful for oral contraception and treat for dysfunctional uterine hemorrhage. | |
| MX358211B (en) | New differential-release pharmaceutical composition containing three active principles. | |
| CR9324A (en) | PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION | |
| PE20091695A1 (en) | PHARMACEUTICAL COMBINATION OF DROSPIRENONE AND 17ß-ESTRADIOL | |
| CL2012003685A1 (en) | Pharmaceutical kit comprising one or more packaging units comprising 21 to 28 daily active dosing units in which each comprises at least 2 mg of drosperidone, without spoiling us; use of the kit and a pharmaceutical composition comprising drosperidone to prepare a useful medication as a contraceptive. | |
| UY29379A1 (en) | PERORAL PHARMACEUTICAL FORM OUTPUT FOR ANTI-CONCEPT | |
| CU20090062A7 (en) | USE OF ESTRADIOL VALERATE OR 17BETA-ESTRADIOL IN COMBINATION WITH DIENOGEST IN AN ORAL THERAPY TO MAINTAIN AND / OR INCREASE THE FEMALE LIBID | |
| DOP2007000122A (en) | PERORAL PHARMACOLOGICAL FORM FOR CONTRACEPTION | |
| PA8793901A1 (en) | USE OF GESTAGANS IN COMBINATION WITH (6S) -5-METHYLTHETHRAHYDROPHOLATE FOR THERAPY ENDOMETRIOSIS WITH SIMULTANEOUS REDUCTION OF THERAPEUTIC COLLATERAL EFFECTS, AND REDUCTION OF THE RISK OF CONGENITAL MALFORMATIONS AT THE BEGINNING OF BEGINNING | |
| DOP2009000079A (en) | USE OF ESTRADIOL VALERATE IN COMBINATION WITH DIENOGEST IN AN ORAL THERAPY TO MAINTAIN AND / OR INCREASE THE FEMALE LIBID | |
| TH2001005863A (en) | Compounds and their uses to relieve symptoms associated with menopause | |
| WO2009112232A3 (en) | New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen | |
| WO2012031999A3 (en) | Low-dose transdermal patches with high drug release | |
| UY29378A1 (en) | PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION | |
| HRP20020666A8 (en) | Drospirenone for hormone replacement therapy | |
| TH80557A (en) | Pharmaceutical products for oral contraception |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |